Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production

FDA: Accelerated approval for Genmab and Seagen’s TIVDAK
The FDA has granted accelerated approval for Genmab and Seagen’s TIVDAK (tisotumab vedotin-tftv), the first and only approved antibody-drug conjugate...
AstraZeneca to invest $340 million on Irish site
AstraZeneca has announced on Tuesday a $340 million plan to establish an active pharmaceutical ingredient (API) manufacturing facility for small...
Vectura removed from DDL Conference amid PMI deal
Inhaler and medical device maker Vectura has been removed from pharma conferences Formulation and Delivery UK and Drug Delivery to the Lungs (DDL)...
Sajid Javid: Valneva COVID vaccine would not have been approved by MHRA
On Monday the UK cancelled a deal with French vaccine maker Valneva worth up to €1.4 billion, and Health Secretary Sajid Javid has now said that this...
>> More Manufacturing and Production News Stories

Features

Medical cannabis: The next innovation in oncology?

The market for medical cannabis has been growing steadily over the last decade, but it may be on the cusp of a breakthrough in oncology. Kat...

>> More Features

Appointments

Stelis Biopharma appoints Mark Womack as new CEO

Stelis Biopharma Limited has announced the appointment of Mark W Womack as the new Chief Executive Officer.

Womack is also the Managing...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches